James J. O’Byrne

1.0k citations
24 papers · 174 indexed · h-index 8
Topics
Genomics and Rare Diseases (8 papers)BRCA gene mutations in cancer (5 papers)Retinal Development and Disorders (5 papers)

In The Last Decade

James J. O’Byrne

18 papers receiving 170 citations

Peers

James J. O’Byrne
Comparison fields: 5 of 49
  • Molecular Biology 95
  • Genetics 81
  • Ophthalmology 28
  • Clinical Biochemistry 16
  • Pathology and Forensic Medicine 13
Replace Taku Omata with:
Taku Omata Japan
Joseph Bursztyn France
Nada Quercia Canada
Alan Kwong United States
Deepa Krishnakumar United Kingdom
Ilaria Viganò Italy
Kimiaki Uetake Japan
Rowena S. James United Kingdom
Ignacio Arroyo Spain
A. Kohlschuetter Germany
James J. O’Byrne relative to Taku Omata Japan Taku Omata's profile →
Citations per field
00.5×5.6×
Taku Omata · 1×
Citations per year

Countries citing papers authored by James J. O’Byrne

Since Specialization
Citations

This map shows the geographic impact of James J. O’Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. O’Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. O’Byrne more than expected).

Fields of papers citing papers by James J. O’Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. O’Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. O’Byrne. The network helps show where James J. O’Byrne may publish in the future.

Co-authorship network of co-authors of James J. O’Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of James J. O’Byrne. A scholar is included among the top collaborators of James J. O’Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. O’Byrne. James J. O’Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 24
5 7
6 4
7 5
8 11
9 5
10 11
11 0
12 6
13 12
14 34
15 0
16 2
17 8
18 22
19 2
20 3

About James J. O’Byrne

James J. O’Byrne is a scholar working on Clinical Biochemistry, Ophthalmology and Genetics, having authored 24 papers that have together received 174 indexed citations. Recurring topics across this work include Genomics and Rare Diseases (8 papers), BRCA gene mutations in cancer (5 papers) and Retinal Development and Disorders (5 papers). The work is most often cited by research in Ophthalmology (28 citations), Genetics (81 citations) and Clinical Biochemistry (16 citations). James J. O’Byrne has collaborated with scholars based in Ireland, United Kingdom and Australia. Frequent co-authors include Adrian Dockery, David Keegan, Jacqueline A. Turner, Laura Whelan, Kirk Stephenson, Eileen P. Treacy, Julia Zhu, G. Jane Farrar, Sally Ann Lynch and Paul F. Kenna. Their work appears in journals such as Neurology, International Journal of Molecular Sciences and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026